Answers are grounded in this paper and cite their sources.
No AccessJournal of UrologyINVESTIGATIVE UROLOGY1 Dec 2002Effects of γ-Aminobutyrate B Receptor Modulation on Normal Micturition and Oxyhemoglobin Induced Detrusor Overactivity in Female Rats RIKARD PEHRSON, ANDERS LEHMANN, and KARL-ERIK ANDERSSON RIKARD PEHRSONRIKARD PEHRSON More articles by this author , ANDERS LEHMANNANDERS LEHMANN More articles by this author , and KARL-ERIK ANDERSSONKARL-ERIK ANDERSSON More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)64247-4AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Using baclofen (Sigma-Aldrich, Steinheim, Germany), a γ-aminobutyrate B (GABA(B)) receptor agonist, and CGP62349 (AstraZeneca R & D Mölndal, Sweden), a GABA(B) receptor antagonist, in a rat model of conscious micturition we addressed certain questions, including whether there is a tonic GABA(B) receptor influence on normal bladder function, how baclofen affects normal and C-fiber activated micturition, and where the sites of GABA(B) receptor action are. Materials and Methods: Nonanesthetized female Sprague-Dawley rats were used. The bladder was catheterized and other catheters were placed intravenously, intrathecally or intracerebroventricularly. At 3 days the rats underwent cystometric investigation in a metabolic cage. Micturition was stimulated by infusing saline intravesically. Overactivity caused by C-fiber activation was induced by intravesical oxyhemoglobin. Drugs were given intravenously, intrathecally or intracerebroventricularly. Micturition parameters were recorded and compared before and after drug administration Results: Baclofen at doses of 0.5 μg. intrathecally and 0.3 μg. intracerebroventricularly increased bladder capacity and threshold pressure. Overflow incontinence developed in 4 of 7 rats after 0.5 μg. baclofen intrathecally and in 5 of 7 after 1 μg. baclofen intracerebroventricularly. CGP62349 at a dose of 30 μg. intrathecally and intracerebroventricularly had a stimulatory effect on micturition, which was attenuated by baclofen. While intravenous baclofen at 1 mg. kg.−1 was devoid of effects, intravenous baclofen at 4 mg. kg.−1 tended to decrease micturition pressure, bladder capacity and micturition volume. Infusion volume decreased significantly, demonstrating a diuretic effect, which was abolished by pretreatment with subcutaneous desmopressin at 25 ng. kg.−1. CGP62349 at 2 mg. kg.−1 intravenously had a stimulatory effect on micturition, which was inhibited by baclofen. Intravesical oxyhemoglobin at 250 μM. induced bladder overactivity, which was attenuated by baclofen at 4 mg. kg.−1 intravenously and abolished by baclofen 0.5 μg intrathecally. Conclusions: In the normal rat stimulation of GABA(B) receptors, mainly in the central nervous system, inhibits micturition. Antagonism of GABA(B) receptors stimulates micturition, suggesting that the receptors are under tonic GABAergic influence. Baclofen intrathecally attenuated oxyhemoglobin induced detrusor overactivity, suggesting that the inhibitory actions of GABA(B) receptor agonists in the spinal cord may be useful for controlling micturition disorders caused by C-fiber activation in the urothelium and/or suburothelium. References 1 : Receptor localization in the mammalian dorsal horn and primary afferent neurons. Brain Res Brain Res Rev1997; 24: 28. Crossref, Medline, Google Scholar 2 : GABAB receptor pharmacology. Annu Rev Pharmacol Toxicol1993; 33: 109. Crossref, Medline, Google Scholar 3 : Effects of GABA-receptor stimulation and blockade on micturition in normal rats and rats with bladder outflow obstruction. J Urol1993; 150: 537. Link, Google Scholar 4 : A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system. Prog Neurobiol1995; 46: 423. Crossref, Medline, Google Scholar 5 : The effects of baclofen on spinal and supraspinal micturition reflexes in rats. Naunyn Schmiedebergs Arch Pharmacol1987; 336: 197. Crossref, Medline, Google Scholar 6 : Effect of the GABAB antagonist, phaclofen, on baclofen-induced inhibition of micturition reflex in urethane-anesthetized rats. Neuroscience1992; 48: 217. Crossref, Medline, Google Scholar 7 : Spinal and supraspinal components of GABAergic inhibition of the micturition reflex in rats. J Pharm Exp Ther1987; 240: 998. Medline, Google Scholar 8 : Effects of tiagabine, a gamma-aminobutyric acid re-uptake inhibitor, on normal rat bladder function. J Urol2002; 167: 2241. Link, Google Scholar 9 : Intravesical oxyhemoglobin initiates bladder overactivity in conscious, normal rats. J Urol2000; 164: 545. Link, Google Scholar 10 : Baclofen inhibits more effectively C-afferent than Adelta-afferent glutamatergic transmission in substantia gelatinosa neurons of adult rat spinal cord slices. Pain2000; 86: 273. Crossref, Medline, Google Scholar 11 : Synthesis and in vivo evaluation of [(11)C]CGP62349, a new GABA(B) receptor antagonist. Nucl Med Biol2000; 27: 565. Crossref, Medline, Google Scholar 12 : GABA and its receptors in the spinal cord. Trends Pharm Sci1996; 17: 457. Crossref, Medline, Google Scholar 13 : Phaclofen-insensitive presynaptic inhibitory action of (+/−)-baclofen in neonatal rat motoneurones in vitro. Br J Pharmacol1990; 99: 413. Crossref, Medline, Google Scholar 14 : Synaptic control of motoneuronal excitability. Physiol Rev2000; 80: 767. Crossref, Medline, Google Scholar 15 : The pontine micturition center projects to sacral cord GABA immunoreactive neurons in the cat. Neurosci Lett1997; 233: 109. Crossref, Medline, Google Scholar 16 : Opposite effects of GABAB receptor antagonists on absences and convulsive seizures. Eur J Pharmacol1997; 332: 245. Crossref, Medline, Google Scholar 17 : Distribution of GABA(B) receptor mRNAs in the rat brain and peripheral organs. Life Sci1999; 64: 1321. Crossref, Medline, Google Scholar 18 : Characterisation of GABAB ligands in vivo. Gen Pharmacol1995; 26: 417. Crossref, Medline, Google Scholar 19 : Presynaptic GABA(B) receptors modulate organum vasculosum lamina terminalis-evoked postsynaptic currents in rat hypothalamic supraoptic neurons. Neuroscience2000; 98: 129. Crossref, Medline, Google Scholar 20 : Antidiuretic action of 1-deamino-(8-D-arginine)-vasopressin in unanesthetized rats. J Pharmacol Exp Ther1974; 188: 241. Medline, Google Scholar From the Department of Clinical Pharmacology, Lund University Hospital, Lund and Departments of Gastrointestinal Biology and Integrative Pharmacology, AstraZeneca R & D Mölndal, Mölndal, Sweden© 2002 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited by Yoshimura N, Takaoka E, Suzuki T and Kwon J (2022) Pharmacology of the Lower Urinary Tract Handbook of Neurourology, 10.1007/978-981-16-7939-1_8-1, (1-9), . Ness T, Randich A, Su X, DeWitte C and Hildebrand K (2021) Systemic and intrathecal baclofen produce bladder antinociception in ratsBMC Urology, 10.1186/s12894-021-00899-0, VOL. 21, NO. 1 Yoshimura N, Takaoka E, Suzuki T and Kwon J (2019) Pharmacology of the Lower Urinary Tract Neurourology, 10.1007/978-94-017-7509-0_8, (79-111), . Fuller T, Jiang X, Bansal U, Lamm V, Shen B, Wang J, Roppolo J, de Groat W and Tai C (2017) Sex difference in the contribution of GABA B receptors to tibial neuromodulation of bladder overactivity in cats American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 10.1152/ajpregu.00401.2016, VOL. 312, NO. 3, (R292-R300), Online publication date: 1-Mar-2017. Vaidyanathan S, Oo T, Soni B, Hughes P and Singh G (2016) Severe, Protracted Spasm of Urinary Bladder and Autonomic Dysreflexia Caused by Changing the Suprapubic Catheter in a Cervical Spinal Cord Injury Patient: Treatment by a Bolus Dose and Increased Total Daily Dose of Intrathecal BaclofenClinical Medicine Insights: Case Reports, 10.4137/CCRep.S39117, VOL. 9, (CCRep.S39117), Online publication date: 1-Jan-2016. de Groat W, Griffiths D and Yoshimura N (2014) Neural Control of the Lower Urinary Tract Comprehensive Physiology, 10.1002/cphy.c130056, (327-396) Kalinichev M, Palea S, Haddouk H, Royer-Urios I, Guilloteau V, Lluel P, Schneider M, Saporito M and Poli S (2014) ADX71441, a novel, potent and selective positive allosteric modulator of the GABA B receptor, shows efficacy in rodent models of overactive bladder British Journal of Pharmacology, 10.1111/bph.12517, VOL. 171, NO. 4, (995-1006), Online publication date: 1-Feb-2014. Andersson K (2011) Physiology and Pharmacology of the Bladder Practical Urology: Essential Principles and Practice, 10.1007/978-1-84882-034-0_9, (123-138), . Lowenstein L (2010) Sensory UrgencyFemale Pelvic Medicine & Reconstructive Surgery, 10.1097/SPV.0b013e3181fae261, VOL. 16, NO. 6, (313-319), Online publication date: 1-Nov-2010. Chen M, Shen B, Wang J, Liu H, Roppolo J, de Groat W and Tai C (2010) Influence of naloxone on inhibitory pudendal-to-bladder reflex in catsExperimental Neurology, 10.1016/j.expneurol.2010.04.003, VOL. 224, NO. 1, (282-291), Online publication date: 1-Jul-2010. Masuda H, Ichiyanagi N, Yokoyama M, Sakai Y, Kihara K, Chancellor M, de Groat W and Yoshimura N (2009) Muscarinic receptor activation in the lumbosacral spinal cord ameliorates bladder irritation in rat cystitis modelsBJU International, 10.1111/j.1464-410X.2009.08617.x, VOL. 104, NO. 10, (1531-1537), Online publication date: 1-Nov-2009. Malherbe P, Masciadri R, Norcross R, Knoflach F, Kratzeisen C, Zenner M, Kolb Y, Marcuz A, Huwyler J, Nakagawa T, Porter R, Thomas A, Wettstein J, Sleight A, Spooren W and Prinssen E (2009) Characterization of ( R , S )-5,7-di- tert -butyl-3-hydroxy-3-trifluoromethyl-3 H -benzofuran-2-one as a positive allosteric modulator of GABA B receptors British Journal of Pharmacology, 10.1038/bjp.2008.135, VOL. 154, NO. 4, (797-811), Online publication date: 1-Jun-2008. Lazzeri M and Porena M (2007) The Challenge of the Overactive Bladder: From Laboratory to New DrugsEAU-EBU Update Series, 10.1016/j.eeus.2007.08.002, VOL. 5, NO. 6, (250-258), Online publication date: 1-Dec-2007. Froestl W and Enna S (2007) CGP 62349 xPharm: The Comprehensive Pharmacology Reference, 10.1016/B978-008055232-3.62928-9, (1-4), . Lazzeri M and Spinelli M (2006) The challenge of overactive bladder therapy: alternative to antimuscarinic agentsInternational braz j urol, 10.1590/S1677-55382006000600002, VOL. 32, NO. 6, (620-630), Online publication date: 1-Dec-2006. Cruz C, McMahon S and Cruz F (2006) Spinal ERK activation contributes to the regulation of bladder function in spinal cord injured ratsExperimental Neurology, 10.1016/j.expneurol.2006.01.016, VOL. 200, NO. 1, (66-73), Online publication date: 1-Jul-2006. Klausner A, Streng T, Na Y, Raju J, Batts T, Tuttle J, Andersson K and Steers W (2005) The role of corticotropin releasing factor and its antagonist, astressin, on micturition in the ratAutonomic Neuroscience, 10.1016/j.autneu.2005.08.003, VOL. 123, NO. 1-2, (26-35), Online publication date: 1-Dec-2005. MIYAZATO M, SUGAYA K, NISHIJIMA S, ASHITOMI K, MOROZUMI M and OGAWA Y (2018) DIETARY GLYCINE INHIBITS BLADDER ACTIVITY IN NORMAL RATS AND RATS WITH SPINAL CORD INJURYJournal of Urology, VOL. 173, NO. 1, (314-317), Online publication date: 1-Jan-2005. Andersson K and Wein A (2004) Pharmacology of the Lower Urinary Tract: Basis for Current and Future Treatments of Urinary IncontinencePharmacological Reviews, 10.1124/pr.56.4.4, VOL. 56, NO. 4, (581-631), Online publication date: 1-Dec-2004. STRENG T, CHRISTOPH T and ANDERSSON K (2018) URODYNAMIC EFFECTS OF THE K+ CHANNEL (KCNQ) OPENER RETIGABINE IN FREELY MOVING, CONSCIOUS RATSJournal of Urology, VOL. 172, NO. 5, (2054-2058), Online publication date: 1-Nov-2004. Bettler B, Kaupmann K, Mosbacher J and Gassmann M (2004) Molecular Structure and Physiological Functions of GABA B Receptors Physiological Reviews, 10.1152/physrev.00036.2003, VOL. 84, NO. 3, (835-867), Online publication date: 1-Jul-2004. Andersson K (2004) New pharmacologic targets for the treatment of the overactive bladder: an updateUrology, 10.1016/j.urology.2003.10.005, VOL. 63, NO. 3, (32-41), Online publication date: 1-Mar-2004. Andersson K and Pehrson R (2003) CNS Involvement in Overactive BladderDrugs, 10.2165/00003495-200363230-00003, VOL. 63, NO. 23, (2595-2611), . Volume 168Issue 6December 2002Page: 2700-2705 Advertisement Copyright & Permissions© 2002 by American Urological Association, Inc.Keywordsrats, Sprague-Dawleymuscle, smoothurinationGABA agonistsbladderMetricsAuthor Information RIKARD PEHRSON More articles by this author ANDERS LEHMANN More articles by this author KARL-ERIK ANDERSSON More articles by this author Expand All Advertisement PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Pehrson et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: